Higher levels of the urinary albumin-to-creatinine ratio (UACR) are associated with adverse clinical outcomes, such as end-stage kidney disease, cardiovascular disease (CVD), and mortality1–5. This evidence concerns the gene ALB and cardiovascular disorder.